For example, in some preclinical and observational studies, liraglutide, one of the most widely used GLP-1 RAs, was associated with an increased incidence of thyroid C-cell hyperplasia and carcinomas, particularly in rodent models, where GLP-1 receptors are more abundantly expressed in thyroid tissue than in humans [15]. This evidence concerns the gene GLP1R and carcinoma.